- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 5th, 2005
Jack Uldrich: First, pSivida announced that it is acquiring Boston-based Control Delivery Systems, a U.S. drug-delivery company, for $104 million. The deal, if shareholders of both companies approve, will go a long way toward helping pSivida capitalize on its plans to commercialize its BioSilicon drug delivery platform.
Starpharma, meanwhile, announced that it has received $20 million grant from the U.S.-based National Institute of Allergy and Infectious Diseases to help accelerate the progress of VivaGel to market.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016